Al-Katib A - Search Results

1

Composite Lymphoma: Opposite Ends of Spectrum Meet.

Khan U, Hadid T, Ibrar W, Sano D, Al-Katib A. Khan U, et al. Among authors: al katib a. J Clin Med Res. 2017 Mar;9(3):213-215. doi: 10.14740/jocmr2929w. Epub 2017 Jan 25. J Clin Med Res. 2017. PMID: 28179969 Free PMC article.

2

Primary Cardiac Lymphoma: Lessons Learned from a Long Survivor.

Singh B, Ip R, Ibrahim Al-Rajjal A, Kafri Z, Al-Katib A, Hadid T. Singh B, et al. Among authors: al katib a. Case Rep Cardiol. 2016;2016:7164829. doi: 10.1155/2016/7164829. Epub 2016 Dec 7. Case Rep Cardiol. 2016. PMID: 28053792 Free PMC article.

3

Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community setting.

Hadid T, Raufi A, Kafri Z, Mandziara M, Kalabat J, Szpunar S, Kolizeras K, Steigelman M, Al-Katib A. Hadid T, et al. Nucl Med Biol. 2016 Apr;43(4):227-31. doi: 10.1016/j.nucmedbio.2015.12.004. Epub 2016 Jan 6. Nucl Med Biol. 2016. PMID: 27067042

4

Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy.

Al-Katib AM, Gaith H, Sano D, Al-Katib S, Bonnett M, Kafri Z. Al-Katib AM, et al. Clin Case Rep. 2020 Jul 15;8(9):1797-1801. doi: 10.1002/ccr3.3019. eCollection 2020 Sep. Clin Case Rep. 2020. PMID: 32983498 Free PMC article.

5

Thrombotic thrombocytopenic purpura presenting as acute coronary syndrome.

Mouabbi JA, Zein R, Kafri Z, Al-Katib A, Hadid T. Mouabbi JA, et al. Clin Case Rep. 2016 Jun 21;4(8):736-9. doi: 10.1002/ccr3.606. eCollection 2016 Aug. Clin Case Rep. 2016. PMID: 27525072 Free PMC article.

6

Coagulation and anticoagulation in COVID-19.

Hadid T, Kafri Z, Al-Katib A. Hadid T, et al. Among authors: al katib a. Blood Rev. 2021 May;47:100761. doi: 10.1016/j.blre.2020.100761. Epub 2020 Oct 8. Blood Rev. 2021. PMID: 33067035 Free PMC article. Review.

7

Superior antitumor activity of SAR3419 to rituximab in xenograft models for non-Hodgkin's lymphoma.

Al-Katib AM, Aboukameel A, Mohammad R, Bissery MC, Zuany-Amorim C. Al-Katib AM, et al. Clin Cancer Res. 2009 Jun 15;15(12):4038-45. doi: 10.1158/1078-0432.CCR-08-2808. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509168

8

Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.

Mohammad RM, Goustin AS, Aboukameel A, Chen B, Banerjee S, Wang G, Nikolovska-Coleska Z, Wang S, Al-Katib A. Mohammad RM, et al. Clin Cancer Res. 2007 Apr 1;13(7):2226-35. doi: 10.1158/1078-0432.CCR-06-1574. Clin Cancer Res. 2007. PMID: 17404107

9

Hematologic malignancies: newer strategies to counter the BCL-2 protein.

Ebrahim AS, Sabbagh H, Liddane A, Raufi A, Kandouz M, Al-Katib A. Ebrahim AS, et al. J Cancer Res Clin Oncol. 2016 Sep;142(9):2013-22. doi: 10.1007/s00432-016-2144-1. Epub 2016 Apr 4. J Cancer Res Clin Oncol. 2016. PMID: 27043233 Review.

10

Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Varterasian ML, Mohammad RM, Shurafa MS, Hulburd K, Pemberton PA, Rodriguez DH, Spadoni V, Eilender DS, Murgo A, Wall N, Dan M, Al-Katib AM. Varterasian ML, et al. Clin Cancer Res. 2000 Mar;6(3):825-8. Clin Cancer Res. 2000. PMID: 10741703 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page